Filter programs:

52 Programs

  • Microlearning Activity

    Recent Developments in the Management of Relapsed/Refractory Multiple Myeloma from ASH 2025: BCMA-Targeted Therapy and Investigational Agents

    Explore program
  • Oncology Today with Dr Neil Love

    Current and Future Role of CD19 x CD3 Bispecific T-Cell Engaging Antibodies in the Treatment of Acute Lymphoblastic Leukemia

    Explore program
  • Webinar Proceedings

    Inside the Issue: The Emerging Role of Cereblon E3 Ligase Modulators in Multiple Myeloma

    Explore program
  • Webinar Proceedings

    Cases from the Community: Investigators Discuss Available Research Guiding the Management of Relapsed/Refractory Multiple Myeloma — What Happened at ASH 2025?

    Explore program